Delivery Order SPE2DB20D3303-SPE2DB25FZ0B7

Award Date 2/4/25
Potential Completion Date 2/26/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $6,370.00 and a completion date of February 13, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, with an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BRUKINSA 80 MG CAPSULE 120S. The firm-fixed-price contract has a ceiling value of $14,984.88 and an ultimate completion date of January 2, 2025. It was awarded on December 10, 2024 as a delivery order, and is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The award has a ceiling value of $14,484.30 and is a firm fixed price contract with a completion date of September 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $7,492.44, is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has a firm fixed-price delivery order type with a ceiling value of $7,492.44 and a period of performance through January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a Delivery Order worth $14,484.30 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a period of performance ending on September 17, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical and a $750,000 IDC with the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,984.88 firm fixed-price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price of $14,484.30 and a completion date of November 5, 2024. This award is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty medication. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ0B7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $6,370.00 and a period of performance through February 26, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/6/25, 11:45 AM